期刊
CELL
卷 165, 期 1, 页码 45-60出版社
CELL PRESS
DOI: 10.1016/j.cell.2016.02.025
关键词
-
资金
- Memorial Sloan Kettering Cancer Center (MSKCC) Genomics Core Facility and Molecular Cytology Core Facility
- NIH [P01-CA094060, P01-CA129243, P30-CA008748]
- DOD Innovator Award [W81XWH-12-1-0074]
- American Cancer Society post-doctoral fellowship
Metastasis frequently develops years after the removal of a primary tumor, from a minority of disseminated cancer cells that survived as latent entities through unknown mechanisms. We isolated latency competent cancer (LCC) cells from early stage human lung and breast carcinoma cell lines and defined the mechanisms that suppress outgrowth, support long-term survival, and maintain tumor-initiating potential in these cells during the latent metastasis stage. LCC cells show stem-cell-like characteristics and express SOX2 and SOX9 transcription factors, which are essential for their survival in host organs under immune surveillance and for metastatic outgrowth under permissive conditions. Through expression of the WNT inhibitor DKK1, LCC cells self-impose a slow-cycling state with broad downregulation of ULBP ligands for NK cells and evasion of NK-cell-mediated clearance. By expressing a Sox-dependent stem-like state and actively silencing WNT signaling, LCC cells can enter quiescence and evade innate immunity to remain latent for extended periods.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据